Dosidal · Poland
Cevenfacta
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Poland |
|---|---|
| Record | pl:presentation:147271 (version 1) |
| Level | presentation |
| Pack code | not anchored |
| Identifiers | rpl-pack-id: 147271 eu-number: EU/1/22/1664/003 |
| Source authority | URPL |
| Read date | 2026-11-15T02:02:49Z |
| controlled status | availability_category: Rpz definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf narcotic_or_psychotropic: False state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| identity | atc: B02BD08 deleted: False eu_pack_number: EU/1/22/1664/003 form: Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań holder: Laboratoire français du Fractionnement et des Biotechnologies medicine: Cevenfacta pack_units: informacjeDodatkowe: + 1 tłok + zabezpieczenie jednostkaPojemnosci: ml liczbaOpakowan: 1 pojemnosc: 5,2 rodzajOpakowania: amp.-strzyk.; informacjeDodatkowe: + 1 adapter jednostkaPojemnosci: mg liczbaOpakowan: 1 pojemnosc: 5 rodzajOpakowania: fiol. procedure: CEN routes: dożylna strength: 5 mg substances: amount: 5 substance: eptakog beta unit: mg state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| pack product code | state: unknown |
| prescription class | availability_category: Rpz definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf prescription: True state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53Hy-_Qpmo50ffHCNShX02ilxWaBAiM9d4eCFHRlW4PJvXiKDfy1bPLCqdZKf-Hl9pLXkALAwnIcjxqGZqbIVD7gVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/pl:presentation:147271 · Related records in other markets · Dosidal